Typicality: | 0.389 |
Saliency: | 0.531 |
to placebo on primary outcome measures | 7 | other |
to placebo | 4 | other |
fluoxetine → be → superior | 12 |
fluoxetine → be → more effective | 4 |
negative | neutral | positive |
0.046 | 0.380 | 0.574 |
Raw frequency | 16 |
Normalized frequency | 0.531 |
Modifier score | 0.500 |
Perplexity | 37.742 |